Imeglimin Hydrochloride
Therapeutic Category
- Anti-diabetic
Innovator Brand
GMP
DMF
Filed
Under Filing
Sample
Indication
Imeglimin known under the brand name of Twymeeg, is an oral anti-diabetic medication. It is an oxidative phosphorylation blocker that acts to inhibit hepatic gluconeogenesis, increase muscle glucose uptake, and restore normal insulin secretion.
CTX Lifesciences, is one of the leading Active Pharmaceutical Ingredients ( API ) manufacturer and supplier globally for Imeglimin Hydrochloride with CAS Number: 775351-65-0. We are a leading exporter of Imeglimin Hydrochloride with CAS Number: 775351-65-0. We are a trusted supplier with API exports in more than 87 Countries including the US, Europe, Brazil, Latin America, China, Korea,Middle East and other emerging markets.
CTX Lifesciences is one of the leading API manufacturer & supplier of Imeglimin Hydrochloride with CAS Number: 775351-65-0. This product is provided from our GMP compliant plant with product made under complete cGMP conditions. We provided with documentation support Drug Master File ( DMF ). Our manufacturing plant at Surat has accreditation by US-FDA, EDQM, EMA, ANVISA, KFDA, Health Canada & Russian Authorities.
CTX also offers other Dipeptidyl peptidase-4( DDP-4 ) inhibitor as mentioned below. Please check them out below.
CTX also offers Sodium/glucose cotransporter 2 inhibitors (also called gliflozins or flozins) , a class of medications that inhibit sodium-glucose transport proteins in the nephron (the functional units of the kidney). Please check them below.
Empagliflozin
Disclaimer: CTX Lifesciences respects patent laws and conventions of pharmaceuticals as applicable in different countries.
API/Substances covered by patent are not offered to the countries where the patent law is in force. However, the final responsibility lies with the customer.